Anzeige
Mehr »
Login
Freitag, 05.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Eilmeldung für Freitag: Nach teils 150% Kursplus an einem Handelstag erneut im Fokus
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.02.New survival data for Merck, Eisai's Keytruda/Lenvima combo shows promise in kidney cancer
15.02.Pfizer's basic instincts
12.02.STEM founder Rob Wood secures a 25% stake in performance-io
12.02.EMA begins rolling review of CureVac's COVID-19 vaccine
12.02.Sandoz to acquire GSK's cephalosporin antibiotic brands for up to $500m
12.02.Roche's anti-inflammatory drug reduces deaths in hospitalised COVID-19 patients
12.02.Virgo Health appoints Sarah Gordon as head of health
11.02.NICE turns down bluebird bio's gene therapy Zynteglo
11.02.Q&A: Emily Spilko
11.02.WHO backs AZ/Oxford COVID-19 vaccine, including in older adults
11.02.AZ forecasts growth in 2021 after revenues surge in Q4
11.02.AZ partners with IDT Biologika to bolster manufacturing for COVID-19 vaccine in EU
11.02.Diana Evans joins Makara Health's leadership team as director
11.02.A Community of Purpose
10.02.ICER extends evaluation of Biogen's aducanumab after FDA delay
10.02.Communiqué Awards 2021 are open for entry!
10.02.FDA grants emergency use for Lilly's COVID-19 antibody drug combination
10.02.NIH trial of AZ's long-acting COVID-19 antibody launches in the US
10.02.Verily and Janssen to collaborate on home-based COVID-19 immune response study
10.02.The remote working revolution
10.02.Eli Lilly promotes Anat Ashkenazi to chief financial officer
09.02.FDA considers new safety warnings for Pfizer's JAK inhibitor Xeljanz
09.02.EU orders another 300 million doses of Pfizer/BioNTech's COVID-19 vaccine
09.02.BMS and Exelixis' Opdivo/Cabometyx shows continued benefit in kidney cancer
09.02.Janssen's Erleada improves survival in certain advanced prostate cancer patients